Design, synthesis, anti-tobacco mosaic virus (TMV) activity, and SARs of 7-methoxycryptopleurine derivatives.
Identifieur interne : 001666 ( Main/Exploration ); précédent : 001665; suivant : 001667Design, synthesis, anti-tobacco mosaic virus (TMV) activity, and SARs of 7-methoxycryptopleurine derivatives.
Auteurs : Ziwen Wang [République populaire de Chine] ; Anzheng Feng ; Mingbo Cui ; Yuxiu Liu ; Lizhong Wang ; Qingmin WangSource :
- Chemical biology & drug design [ 1747-0285 ] ; 2014.
Descripteurs français
- KwdFr :
- Alcaloïdes (), Antiviraux (), Antiviraux (pharmacologie), Antiviraux (synthèse chimique), Conception de médicament, Phénanthrolines (), Quinolizines (), Quinolizines (pharmacologie), Relation structure-activité, Tabac (), Tabac (virologie), Techniques de chimie synthétique, Virus de la mosaïque du tabac (), Évaluation préclinique de médicament ().
- MESH :
- pharmacologie : Antiviraux, Quinolizines.
- synthèse chimique : Antiviraux.
- virologie : Tabac.
- Alcaloïdes, Antiviraux, Conception de médicament, Phénanthrolines, Quinolizines, Relation structure-activité, Tabac, Techniques de chimie synthétique, Virus de la mosaïque du tabac, Évaluation préclinique de médicament.
English descriptors
- KwdEn :
- Alkaloids (chemistry), Antiviral Agents (chemical synthesis), Antiviral Agents (chemistry), Antiviral Agents (pharmacology), Chemistry Techniques, Synthetic, Drug Design, Drug Evaluation, Preclinical (methods), Phenanthrolines (chemistry), Quinolizines (chemistry), Quinolizines (pharmacology), Structure-Activity Relationship, Tobacco (drug effects), Tobacco (virology), Tobacco Mosaic Virus (drug effects).
- MESH :
- chemical , chemical synthesis : Antiviral Agents.
- chemical , chemistry : Alkaloids, Antiviral Agents, Phenanthrolines, Quinolizines.
- chemical , pharmacology : Antiviral Agents, Quinolizines.
- drug effects : Tobacco, Tobacco Mosaic Virus.
- methods : Drug Evaluation, Preclinical.
- virology : Tobacco.
- Chemistry Techniques, Synthetic, Drug Design, Structure-Activity Relationship.
Abstract
A series of 7-methoxycryptopleurine derivatives 2-23 were prepared and evaluated for their antiviral activity against tobacco mosaic virus (TMV) for the first time. The bioassay results showed that most of these compounds exhibited excellent in vivo anti-TMV activity, of which 7-methoxycryptopleurine salt derivatives 16, 19, and 23 displayed significantly higher activity than 7-methoxycryptopleurine (1) and commercial ribavirin and ningnanmycin. Salification, the most commonly employed method for modifying physical-chemical properties, did significantly increase antiviral activity, and different salt forms displayed different antiviral effect. This study provides fundamental support for development and optimization of phenanthroquinolizidine alkaloids as potential inhibitors of plant virus.
DOI: 10.1111/cbdd.12340
PubMed: 24751111
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 001006
- to stream PubMed, to step Curation: 001006
- to stream PubMed, to step Checkpoint: 001016
- to stream Ncbi, to step Merge: 002875
- to stream Ncbi, to step Curation: 002875
- to stream Ncbi, to step Checkpoint: 002875
- to stream Main, to step Merge: 001672
- to stream Main, to step Curation: 001666
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Design, synthesis, anti-tobacco mosaic virus (TMV) activity, and SARs of 7-methoxycryptopleurine derivatives.</title>
<author><name sortKey="Wang, Ziwen" sort="Wang, Ziwen" uniqKey="Wang Z" first="Ziwen" last="Wang">Ziwen Wang</name>
<affiliation wicri:level="1"><nlm:affiliation>State Key Laboratory of Elemento-Organic Chemistry, Research Institute of Elemento-Organic Chemistry, Collaborative Innovation Center of Chemical Science and Engineering(Tianjin), Nankai University, Tianjin, 300071, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>State Key Laboratory of Elemento-Organic Chemistry, Research Institute of Elemento-Organic Chemistry, Collaborative Innovation Center of Chemical Science and Engineering(Tianjin), Nankai University, Tianjin, 300071</wicri:regionArea>
<wicri:noRegion>300071</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Feng, Anzheng" sort="Feng, Anzheng" uniqKey="Feng A" first="Anzheng" last="Feng">Anzheng Feng</name>
</author>
<author><name sortKey="Cui, Mingbo" sort="Cui, Mingbo" uniqKey="Cui M" first="Mingbo" last="Cui">Mingbo Cui</name>
</author>
<author><name sortKey="Liu, Yuxiu" sort="Liu, Yuxiu" uniqKey="Liu Y" first="Yuxiu" last="Liu">Yuxiu Liu</name>
</author>
<author><name sortKey="Wang, Lizhong" sort="Wang, Lizhong" uniqKey="Wang L" first="Lizhong" last="Wang">Lizhong Wang</name>
</author>
<author><name sortKey="Wang, Qingmin" sort="Wang, Qingmin" uniqKey="Wang Q" first="Qingmin" last="Wang">Qingmin Wang</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:24751111</idno>
<idno type="pmid">24751111</idno>
<idno type="doi">10.1111/cbdd.12340</idno>
<idno type="wicri:Area/PubMed/Corpus">001006</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001006</idno>
<idno type="wicri:Area/PubMed/Curation">001006</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001006</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001016</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001016</idno>
<idno type="wicri:Area/Ncbi/Merge">002875</idno>
<idno type="wicri:Area/Ncbi/Curation">002875</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">002875</idno>
<idno type="wicri:Area/Main/Merge">001672</idno>
<idno type="wicri:Area/Main/Curation">001666</idno>
<idno type="wicri:Area/Main/Exploration">001666</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Design, synthesis, anti-tobacco mosaic virus (TMV) activity, and SARs of 7-methoxycryptopleurine derivatives.</title>
<author><name sortKey="Wang, Ziwen" sort="Wang, Ziwen" uniqKey="Wang Z" first="Ziwen" last="Wang">Ziwen Wang</name>
<affiliation wicri:level="1"><nlm:affiliation>State Key Laboratory of Elemento-Organic Chemistry, Research Institute of Elemento-Organic Chemistry, Collaborative Innovation Center of Chemical Science and Engineering(Tianjin), Nankai University, Tianjin, 300071, China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>State Key Laboratory of Elemento-Organic Chemistry, Research Institute of Elemento-Organic Chemistry, Collaborative Innovation Center of Chemical Science and Engineering(Tianjin), Nankai University, Tianjin, 300071</wicri:regionArea>
<wicri:noRegion>300071</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Feng, Anzheng" sort="Feng, Anzheng" uniqKey="Feng A" first="Anzheng" last="Feng">Anzheng Feng</name>
</author>
<author><name sortKey="Cui, Mingbo" sort="Cui, Mingbo" uniqKey="Cui M" first="Mingbo" last="Cui">Mingbo Cui</name>
</author>
<author><name sortKey="Liu, Yuxiu" sort="Liu, Yuxiu" uniqKey="Liu Y" first="Yuxiu" last="Liu">Yuxiu Liu</name>
</author>
<author><name sortKey="Wang, Lizhong" sort="Wang, Lizhong" uniqKey="Wang L" first="Lizhong" last="Wang">Lizhong Wang</name>
</author>
<author><name sortKey="Wang, Qingmin" sort="Wang, Qingmin" uniqKey="Wang Q" first="Qingmin" last="Wang">Qingmin Wang</name>
</author>
</analytic>
<series><title level="j">Chemical biology & drug design</title>
<idno type="eISSN">1747-0285</idno>
<imprint><date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Alkaloids (chemistry)</term>
<term>Antiviral Agents (chemical synthesis)</term>
<term>Antiviral Agents (chemistry)</term>
<term>Antiviral Agents (pharmacology)</term>
<term>Chemistry Techniques, Synthetic</term>
<term>Drug Design</term>
<term>Drug Evaluation, Preclinical (methods)</term>
<term>Phenanthrolines (chemistry)</term>
<term>Quinolizines (chemistry)</term>
<term>Quinolizines (pharmacology)</term>
<term>Structure-Activity Relationship</term>
<term>Tobacco (drug effects)</term>
<term>Tobacco (virology)</term>
<term>Tobacco Mosaic Virus (drug effects)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Alcaloïdes ()</term>
<term>Antiviraux ()</term>
<term>Antiviraux (pharmacologie)</term>
<term>Antiviraux (synthèse chimique)</term>
<term>Conception de médicament</term>
<term>Phénanthrolines ()</term>
<term>Quinolizines ()</term>
<term>Quinolizines (pharmacologie)</term>
<term>Relation structure-activité</term>
<term>Tabac ()</term>
<term>Tabac (virologie)</term>
<term>Techniques de chimie synthétique</term>
<term>Virus de la mosaïque du tabac ()</term>
<term>Évaluation préclinique de médicament ()</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemical synthesis" xml:lang="en"><term>Antiviral Agents</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en"><term>Alkaloids</term>
<term>Antiviral Agents</term>
<term>Phenanthrolines</term>
<term>Quinolizines</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Antiviral Agents</term>
<term>Quinolizines</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Tobacco</term>
<term>Tobacco Mosaic Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Drug Evaluation, Preclinical</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Antiviraux</term>
<term>Quinolizines</term>
</keywords>
<keywords scheme="MESH" qualifier="synthèse chimique" xml:lang="fr"><term>Antiviraux</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Tabac</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Tobacco</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Chemistry Techniques, Synthetic</term>
<term>Drug Design</term>
<term>Structure-Activity Relationship</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Alcaloïdes</term>
<term>Antiviraux</term>
<term>Conception de médicament</term>
<term>Phénanthrolines</term>
<term>Quinolizines</term>
<term>Relation structure-activité</term>
<term>Tabac</term>
<term>Techniques de chimie synthétique</term>
<term>Virus de la mosaïque du tabac</term>
<term>Évaluation préclinique de médicament</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">A series of 7-methoxycryptopleurine derivatives 2-23 were prepared and evaluated for their antiviral activity against tobacco mosaic virus (TMV) for the first time. The bioassay results showed that most of these compounds exhibited excellent in vivo anti-TMV activity, of which 7-methoxycryptopleurine salt derivatives 16, 19, and 23 displayed significantly higher activity than 7-methoxycryptopleurine (1) and commercial ribavirin and ningnanmycin. Salification, the most commonly employed method for modifying physical-chemical properties, did significantly increase antiviral activity, and different salt forms displayed different antiviral effect. This study provides fundamental support for development and optimization of phenanthroquinolizidine alkaloids as potential inhibitors of plant virus. </div>
</front>
</TEI>
<affiliations><list><country><li>République populaire de Chine</li>
</country>
</list>
<tree><noCountry><name sortKey="Cui, Mingbo" sort="Cui, Mingbo" uniqKey="Cui M" first="Mingbo" last="Cui">Mingbo Cui</name>
<name sortKey="Feng, Anzheng" sort="Feng, Anzheng" uniqKey="Feng A" first="Anzheng" last="Feng">Anzheng Feng</name>
<name sortKey="Liu, Yuxiu" sort="Liu, Yuxiu" uniqKey="Liu Y" first="Yuxiu" last="Liu">Yuxiu Liu</name>
<name sortKey="Wang, Lizhong" sort="Wang, Lizhong" uniqKey="Wang L" first="Lizhong" last="Wang">Lizhong Wang</name>
<name sortKey="Wang, Qingmin" sort="Wang, Qingmin" uniqKey="Wang Q" first="Qingmin" last="Wang">Qingmin Wang</name>
</noCountry>
<country name="République populaire de Chine"><noRegion><name sortKey="Wang, Ziwen" sort="Wang, Ziwen" uniqKey="Wang Z" first="Ziwen" last="Wang">Ziwen Wang</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001666 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001666 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:24751111 |texte= Design, synthesis, anti-tobacco mosaic virus (TMV) activity, and SARs of 7-methoxycryptopleurine derivatives. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:24751111" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a SrasV1
This area was generated with Dilib version V0.6.33. |